English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  51382110    在线人数 :  838
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"wu s g"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 141-165 / 224 (共9页)
<< < 1 2 3 4 5 6 7 8 9 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-05-26T09:26:56Z IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer Shih J.-Y.;Chih-Hsin Yang;Yu S.-L;Chen H.-Y;Tsai T.-H;Wu S.-G;Tsai M.-F;Chang T.-H;Liu Y.-N; Liu Y.-N; Chang T.-H; Tsai M.-F; Wu S.-G; Tsai T.-H; Chen H.-Y; Yu S.-L; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏 2020-05-26T09:26:53Z Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion Shih J.-Y.;Chih-Hsin Yang;Yu C.-J;Hsieh M.-S;Wu S.-G;Tsai T.-H; Tsai T.-H; Wu S.-G; Hsieh M.-S; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏 2020-05-26T09:26:50Z Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations Shih J.-Y.;Yang P.-C;Chih-Hsin Yang;Yu C.-J;Chang Y.-L;Wu S.-G;Hsieh M.-S;Chen Y.-F; Chen Y.-F; Hsieh M.-S; Wu S.-G; Chang Y.-L; Yu C.-J; CHIH-HSIN YANG; Yang P.-C; Shih J.-Y.
臺大學術典藏 2020-05-26T09:26:48Z The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Shih J.-Y.;Wen Y.-F;Chih-Hsin Yang;Yang P.-C;Yu C.-J;Chang Y.-L;Tsai M.-F;Liu Y.-N;Wu S-G; Wu S-G; Liu Y.-N; Tsai M.-F; Chang Y.-L; Yu C.-J; Yang P.-C; CHIH-HSIN YANG; Wen Y.-F; Shih J.-Y.
臺大學術典藏 2020-05-26T09:26:37Z Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non?�Small-cell Lung Cancer Shih J.-Y.;Chih-Hsin Yang;Wu S.-G;Liu Y.-N;Lin Y.-T; Lin Y.-T; Liu Y.-N; Wu S.-G; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏 2020-05-26T09:26:26Z Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion Shih J.-Y.;Chih-Hsin Yang;Yu C.-J;Liu Y.-N;Wu S.-G; Wu S.-G; Liu Y.-N; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏 2020-05-25T06:51:56Z Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas Wu P.-F;Huang W.-C;Yang J.C.-H;Yen-Shen Lu;Shih J.-Y;Wu S.-G;Lin C.-H;Cheng A.-L.; Wu P.-F; Huang W.-C; Yang J.C.-H; YEN-SHEN LU; Shih J.-Y; Wu S.-G; Lin C.-H; Cheng A.-L.
臺大學術典藏 2020-05-25T01:33:01Z Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer YEN-TING LIN; Wang Y.-F.; Yang J.C.-H.; Yu C.-J.; Wu S.-G.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-05-25T01:32:59Z Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non–Small-cell Lung Cancer YEN-TING LIN; Liu Y.-N.; Wu S.-G.; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏 2020-05-25T01:32:56Z Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer Shih J.-Y.;Yu C.-J.;Liu Y.-N.;Wu S.-G.;Tsai T.-H.;YEN-TING LIN; YEN-TING LIN; Tsai T.-H.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Shih J.-Y.
臺大學術典藏 2020-05-20T05:11:45Z Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer Wu S.-G.; Shih J.-Y.; Yang P.-C.; Yu C.-J.; Yang J.C.-H.; Wang Y.-F.; YEN-TING LIN; Yang P.-C.;Shih J.-Y.;Wu S.-G.;Yu C.-J.;Yang J.C.-H.;Wang Y.-F.;YEN-TING LIN
臺大學術典藏 2020-05-20T05:11:43Z Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non�VSmall-cell Lung Cancer Shih J.-Y.;Yang J.C.-H.;Wu S.-G.;Liu Y.-N.;YEN-TING LIN; YEN-TING LIN; Liu Y.-N.; Wu S.-G.; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏 2020-05-20T05:11:41Z Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer Shih J.-Y.; Yu C.-J.; Liu Y.-N.; Wu S.-G.; Tsai T.-H.; YEN-TING LIN; Shih J.-Y.;Yu C.-J.;Liu Y.-N.;Wu S.-G.;Tsai T.-H.;YEN-TING LIN
臺大學術典藏 2020-03-07T06:56:45Z Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Wu S.-G.; Gow C.-H.; Yu C.-J.; YIH-LEONG CHANG; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:45Z Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response Wu J.-Y.;Wu S.-G.;Yang C.-H.;Gow C.-H.;Yih-Leong Chang;Yu C.-J.;Shin J.-Y.;Yang P.-C.; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; YIH-LEONG CHANG; Yu C.-J.; Shin J.-Y.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:38Z Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations Wu S.-G. ;Yang C.-H. ;Yu C.-J. ;Lee J.-H. ;Hsu Y.-C. ;Yih-Leong Chang ;Shih J.-Y. ;Yang P.-C.; Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; YIH-LEONG CHANG; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:38Z Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction Wu S.-G. ;Yih-Leong Chang ;Lin J.-W. ;Wu C.-T. ;Chen H.-Y. ;Tsai M.-F. ;Lee Y.-C. ;Yu C.-J. ;Shih J.-Y.; Wu S.-G.; YIH-LEONG CHANG; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y.
臺大學術典藏 2020-03-07T06:56:38Z Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Wu J.-Y. ;Wu S.-G. ;Yang C.-H. ;Yih-Leong Chang ;Chang Y.-C. ;Hsu Y.-C. ;Shih J.-Y. ;Yang P.-C.; Wu J.-Y.; Wu S.-G.; Yang C.-H.; YIH-LEONG CHANG; Chang Y.-C.; Hsu Y.-C.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:35Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR Wu S.-G.;Kuo Y.-W.;Yih-Leong Chang;Shih J.-Y.;Chen Y.-H.;Tsai M.-F.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Wu S.-G.; Kuo Y.-W.; YIH-LEONG CHANG; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; Yu C.-J.; Yang C.-H.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:35Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Tsai T.-H.; Wu S.-G.; YIH-LEONG CHANG; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-03-07T06:56:34Z RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer Tsai T.-H.; Su K.-Y.; Wu S.-G.; YIH-LEONG CHANG; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:33Z Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis Wu S.-G.; Hu F.-C.; YIH-LEONG CHANG; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:27Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Yih-Leong Chang;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tsai T.-H.;Yu C.-J.;Yang J.C.-H.;Yang P.-C.; YIH-LEONG CHANG; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.
臺大學術典藏 2020-03-07T06:56:26Z Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: Identification of a rare CD74-NRG1 translocation case Gow C.-H.; Wu S.-G.; YIH-LEONG CHANG; Shih J.-Y.
臺大學術典藏 2020-03-07T06:56:19Z Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Yih-Leong Chang;Yu C.-J.;Yang J.C.-H.;Yang P.-C.;Shih J.-Y.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Shih J.-Y.

显示项目 141-165 / 224 (共9页)
<< < 1 2 3 4 5 6 7 8 9 > >>
每页显示[10|25|50]项目